A StuDy EVAluatiNg the Long-Term EffiCacy and Safety of RalinEpag in Subjects with PAH via an Open-Label EXTENSION
-
- STATUS
- Not Recruiting
Summary
This Phase 3, open-label, multicenter study will be conducted to assess the long-term safety, tolerability, and effectiveness of ralinepag as an add-on therapy in subjects with PAH who have participated in the ADVANCE outcomes study [IRB protocol #832052]. The purpose of this clinical research study is to determine: The purpose of this extension clinical research study is to evaluate the effect of the investigational study drug (ralinepag) over a longer period on the following: Your symptoms of PAH. Your ability to exercise (during a walking test). Your heart rate recovery (how quickly your heart rate slows down after a walking test). Your blood test results and study assessments when used with your current treatment for PAH. Your quality of life. Any side effects that you may have during the study.
Details
| Condition | TBD |
|---|---|
| Age | 99years or below |
| Clinical Study Identifier | TBD |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.